
Alfasigma Streamlines Manufacturing Footprint to Sharpen Strategic Focus and Accelerate Innovation and Growth
Alfasigma, a global pharmaceutical company headquartered in Italy, today announced that it has entered into an agreement for the sale of 100% of the share capital of its subsidiary Sofar S.p.A. (“Sofar”), which includes the production site in Trezzano Rosa, to Fine Foods & Pharmaceuticals N.T.M. S.p.A. (“Fine Foods”).





